Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | RXFP1 | Q9HBX9 | 1/20 | 0.50 |
| ▸ | HDAC1 | Q13547 | 4/20 | 0.47 |
| ▸ | CA1 | P00915 | 2/20 | 0.46 |
| ▸ | CA2 | P00918 | 2/20 | 0.46 |
| ▸ | CA9 | Q16790 | 2/20 | 0.46 |
| ▸ | HDAC6 | Q9UBN7 | 1/20 | 0.46 |
| ▸ | SMN1; SMN2 | Q16637 | 2/20 | 0.44 |
| ▸ | GAA | P10253 | 1/20 | 0.44 |
| ▸ | ALDH1A1 | P00352 | 4/20 | 0.43 |
| ▸ | POLB | P06746 | 2/20 | 0.43 |
| ▸ | MEN1 | O00255 | 1/20 | 0.43 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.43 |
| ▸ | CCNA2 | P20248 | 1/20 | 0.43 |
| ▸ | CDK2 | P24941 | 1/20 | 0.43 |
| ▸ | CCNA1 | P78396 | 1/20 | 0.43 |
| ▸ | HDAC3 | O15379 | 1/20 | 0.43 |
| ▸ | HDAC2 | Q92769 | 1/20 | 0.43 |
| ▸ | NCOR2 | Q9Y618 | 1/20 | 0.43 |
| ▸ | RAB9A | P51151 | 3/20 | 0.43 |
| ▸ | DYRK1A | Q13627 | 2/20 | 0.43 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL375020 | 1.00 | RXFP1 (0.50) | RXFP1HDAC1CA1CA2CA9 | |
| SCHEMBL422893 | 0.85 | CA1 (0.58) | RXFP1HDAC1CA1CA2CA9 | |
| SCHEMBL30559973 | 0.85 | CA1 (0.58) | RXFP1HDAC1CA1CA2CA9 | |
| SCHEMBL1704181 | 0.83 | ALDH1A1 (0.44) | HDAC1HDAC6SMN1; SMN2GAAALDH1A1 | |
| SCHEMBL20560249 | 0.81 | ALOX15 (0.43) | HDAC1HDAC6SMN1; SMN2GAAALDH1A1 | |
| SCHEMBL30748254 | 0.81 | SMN1; SMN2 (0.55) | HDAC1CA1CA2CA9HDAC6 | |
| SCHEMBL8955980 | 0.81 | SMN1; SMN2 (0.55) | HDAC1CA1CA2CA9HDAC6 | |
| SCHEMBL3715354 | 0.81 | ALDH1A1 (0.58) | RXFP1HDAC1CA1CA2CA9 | |
| SCHEMBL28355716 | 0.81 | KMT2A (0.46) | SMN1; SMN2GAAALDH1A1POLBMEN1 | |
| SCHEMBL1282557 | 0.81 | PDK1 (0.45) | CA1CA2CA9GAAALDH1A1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 27 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-4694935-A1 | COMBINATION OF ANTIBODY-DRUG CONJUGATE AND ANTI-PD-1 ANTIBODY, AND USE THEREOF | Genequantum Healthcare (Suzhou) Co., Ltd. (CN) | 2026-02-18 | — | — | EP | disclosed |
| EP-4688871-A1 | SITE-SPEICFIC ORTHOGONAL BIOCONJUGATE MODALITY AND APPLICATION THEREOF | Genequantum Healthcare (Suzhou) Co., Ltd. (CN) | 2026-02-11 | — | — | EP | disclosed |
| EP-4554956-A1 | LINKERS, CONJUGATES AND APPLICATIONS THEREOF | Genequantum Healthcare (Suzhou) Co., Ltd. (CN) | 2025-05-21 | — | — | EP | disclosed |
| EP-4554626-A2 | ANTI-TROP2 ANTIBODY AND CONJUGATE THEREOF | Genequantum Healthcare (Suzhou) Co., Ltd. (CN) | 2025-05-21 | — | — | EP | disclosed |
| EP-4547285-A1 | ANTI-FGFR3 ANTIBODY CONJUGATE AND MEDICAL USE THEREOF | Genequantum Healthcare (Suzhou) Co., Ltd. (CN) | 2025-05-07 | — | — | EP | disclosed |
| CN-119630427-A | Anti-FGFR 3 antibody conjugates and medical uses thereof | 启德医药科技（苏州）有限公司 | 2025-03-14 | — | — | CN | disclosed |
| CN-119497717-A | Linker, conjugate and uses thereof | 启德医药科技（苏州）有限公司 | 2025-02-21 | — | — | CN | disclosed |
| CN-119462943-A | Antibodies, linkers, supports, conjugates and uses thereof | 启德医药科技（苏州）有限公司 | 2025-02-18 | — | — | CN | disclosed |
| WO-2024213091-A9 | COMBINATION OF ANTIBODY-DRUG CONJUGATE AND ANTI-PD-1 ANTIBODY, AND USE THEREOF | GENEQUANTUM HEALTHCARE (SUZHOU) CO., LTD. (CN) | 2024-12-19 | — | — | WO | disclosed |
| CN-118251241-B | Antibodies, linkers, supports, conjugates and uses thereof | 启德医药科技（苏州）有限公司 | 2024-12-13 | — | — | CN | disclosed |
| WO-2024012569-A9 | LINKERS, CONJUGATES AND APPLICATIONS THEREOF | GENEQUANTUM HEALTHCARE (SUZHOU) CO., LTD. (CN) | 2024-03-28 | — | — | WO | disclosed |
| WO-2024012566-A2 | ANTIBODY, LINKERS, PAYLOAD, CONJUGATES AND APPLICATIONS THEREOF | GENEQUANTUM HEALTHCARE (SUZHOU) CO., LTD. (CN) | 2024-01-18 | — | — | WO | disclosed |
| WO-2024012569-A1 | LINKERS, CONJUGATES AND APPLICATIONS THEREOF | GENEQUANTUM HEALTHCARE (SUZHOU) CO., LTD. (CN) | 2024-01-18 | — | — | WO | disclosed |
| WO-2024002154-A1 | ANTI-FGFR3 ANTIBODY CONJUGATE AND MEDICAL USE THEREOF | GENEQUANTUM HEALTHCARE (SUZHOU) CO., LTD. (CN) | 2024-01-04 | — | — | WO | disclosed |
| CN-115990269-B | Esatitecan derivatives and linker-carriers and conjugates thereof | 启德医药科技（苏州）有限公司 | 2023-11-14 | — | — | CN | disclosed |
| CN-112771046-B | Other substituted triazoloquinoxaline derivatives | 格吕伦塔尔有限公司 | 2023-09-19 | — | — | CN | disclosed |
| EP-4211145-A1 | EXATECAN DERIVATIVES, LINKER-PAYLOADS, AND CONJUGATES AND THEREOF | Genequantum Healthcare (Suzhou) Co., Ltd. (CN) | 2023-07-19 | — | — | EP | disclosed |
| WO-2023088235-A1 | EXATECAN DERIVATIVES, LINKER-PAYLOADS, AND CONJUGATES AND THEREOF | GENEQUANTUM HEALTHCARE (SUZHOU) CO., LTD. (CN) | 2023-05-25 | — | — | WO | disclosed |
| CN-115990269-A | Esatitecan derivatives and linker-carriers and conjugates thereof | 启德医药科技（苏州）有限公司 | 2023-04-21 | — | — | CN | disclosed |
| EP-4090660-A1 | QUINOXALINE DERIVATIVES | Grünenthal GmbH (DE) | 2022-11-23 | — | — | EP | disclosed |